GSG Advisors’s Bioventus BVS Stock Holding History

GSG Advisors’s Portfolio BVS Stock Details BVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-26,511	Closed	-$133K	–	105
2024 Q1	$133K	Buy	26,511 +9,500	+56%	+$46.4K	0.05%	105
2023 Q4	$88.8K	Buy	+17,011	New	+$67.3K	0.03%	108

Other funds holding BVS

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

JIC

Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GSG Advisors's BVS Position: Q2 2024 in Review

GSG Advisors sold out of Bioventus (BVS) in Q2 2024, closing a stake of 26,511 shares — an estimated $133K sold.

GSG Advisors first reported a position in BVS in Q4 2023 and held it in 2 quarters. The position peaked at $133K in Q1 2024. 103 funds tracked by Wall St. Rank hold BVS as of Q2 2024.

GSG Advisors reported no remaining Bioventus position as of Q2 2024 after selling out during the quarter.
GSG Advisors sold 26,511 Bioventus shares in Q2 2024, an estimated $133K.
GSG Advisors first reported a position in Bioventus in Q4 2023 and held it in 2 quarters.
GSG Advisors's Bioventus position peaked at $133K in Q1 2024.
103 funds tracked by Wall St. Rank held Bioventus as of Q2 2024.

Based on GSG Advisors's 13F filing for Q2 2024, filed 12 Jul 2024.